Federal Trade Commission
Already concerned with drug costs, large employers, family pharmacists worry about more middlemen
There already were deep concerns among small pharmacists about drug middlemen known as "pharmacy benefit managers." Now the corporations that own them appear to be creating yet another layer of middlemen. That has even the largest employers in the country worried.
Federal regulator’s oversight of the drug supply chain blasted — by one of the regulators
One of two federal agencies tasked with policing anticompetitive behavior among corporations last week said it has a lot more work to do when it comes to the prescription-drug supply chain. One of the members of the Federal Trade Commission went even further. He suggested the agency has abdicated its responsibility as drug prices have […]
Federal probe of drug middlemen urged
After years of accusations in Ohio and elsewhere, a bipartisan group in the U.S. Senate wants federal regulators to investigate whether drug middlemen and their parent companies are rigging the system to raise prices and pad their pockets. Sens. Chuck Grassley, R-Iowa, and Maria Cantwell, D-Wash., last month filed legislation that would require the federal […]